Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models
-
nCino Introduces “Digital Partners,” Role-based Agents Purpose-built to Establish a Dual Workforce for Financial Services
-
Bombardier Global 8000, The World’s Fastest and Longest-Range Four-Zone Business Jet, Now Sets a New Benchmark with the Lowest Cabin Altitude
-
Edible Garden Begins Shipping The Fresh Market
-
Stardust Power Announces Third Quarter 2025 Earnings Release Date, Conference Call
-
BridgeBio to Participate in November Investor Conferences
-
Habit Burger & Grill Celebrates the Season with the Return of the Patty Melt and Two Delicious Holiday Treats
-
TWFG, Inc. Acquires Alabama Insurance Agency, Inc. Expanding Its Southeastern Footprint
-
Kinetic Seas Inc. Announces Landmark Exclusive Partnership with Sagtec Global Limited, Launching Skilliks AI Platform into Southeast Asia
-
Kane Biotech Presents revyve® Data at Diabetic Foot and Southern Region Burn Conferences
-
Debt Trap or Lifeline? Borrower Attitudes Toward Short-Term Loans Revealed in New Study by Radcred
-
Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences
-
Costamare Inc. Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
-
Bitcoin Bancorp Partners with Sailo Technologies to Launch Revolutionary Bitcoin Treasury Management Platform Amid Surge in Corporate Adoption
-
MARA Announces Third Quarter 2025 Results
-
Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights
-
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan
-
Prelude Therapeutics Announces Strategic Business Update
-
Celcuity To Present at Upcoming Stifel 2025 Healthcare Conference
-
Xometry Reports Record Third Quarter 2025 Results
-
Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025
-
OnEquity Earns “Best Multi-Asset Institutional Broker – APAC” at UF AWARDS 2025
-
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
-
Abcourt Announces Arrangements for Upcoming Annual Meeting of Shareholders in Event of Canada Post Service Disruption
-
Geography Shouldn’t Determine Access to Justice: New Report Reveals Deep Inequities in Forensic Evidence Collection for Sexual Assault Survivors in Canada’s Remote and Indigenous Communities
-
Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
-
Dave Reports Third Quarter 2025 Financial Results
-
AmpliTech Group To Release Q3 – 2025 Earnings On November 14th Before Market Opening - Also Announces Investor’s Conference Call
-
Lancaster Resources Expands Footprint in James Bay with Additional Claims at Lac Iris Polymetallic Project
-
Capital City Bank Appoints Alicia Williams-Ronan Chief Retail Officer
-
Kymera Therapeutics Announces Third Quarter 2025 Financial Results and Provides a Business Update
-
Caliber Sets Date for Third Quarter 2025 Earnings Announcement & Investor Conference Call
-
Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates
-
Parex Resources Announces Third Quarter Results, Strong October 2025 Production, and Declaration of Q4 2025 Dividend
-
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
-
Yukon Metals Launches Digital Marketing Campaign
-
Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ
-
Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
SNDL Reports Third Quarter 2025 Financial and Operational Results
-
EDAP to Present at Jefferies Global Healthcare Conference in London
-
First Watch Restaurant Group, Inc. Reports Q3 2025 Financial Results
-
Moisson Montréal Named Among Canada’s Top 10 Most Impactful Food Banks by Charity Intelligence
-
Chicago Atlantic Real Estate Finance Announces Third Quarter 2025 Financial Results
-
Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation
-
Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates
-
Ocular Therapeutix™ Achieves Target Randomization of 555 Subjects in SOL-R
-
Secura Bio Announces Poster Presentation Highlighting Extended Follow Up Analyses from Phase 2 PRIMO Trial at the 2025 American Society of Hematology Meeting
-
Attralus To Present Phase 1/2 Data on Its Pan Amyloid Depleter at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

